Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter Hyperintensity

Ying Zhou1, Rui Xue1, Yifei Li1

  • 1Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.

Insights

White matter hyperintensity (WMH) is linked to cognitive decline. Impaired lymphatic drainage exacerbates WMH, but enhancing meningeal lymphangiogenesis may offer a new treatment strategy.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Immunology

Background:

  • White matter hyperintensity (WMH) is a significant concern associated with cognitive decline and dementia.
  • The precise mechanisms driving WMH progression remain largely unknown.
  • Dysfunction in brain clearance pathways, including meningeal lymphatics and the glymphatic system, is implicated.

Purpose of the Study:

  • To investigate the relationship between WMH burden and the function of meningeal lymphatic vessels (mLVs) and the glymphatic pathway.
  • To explore the role of lymphangiogenesis and glymphatic drainage in WMH pathogenesis using a rat model.
  • To evaluate the therapeutic potential of modulating mLVs for WMH treatment.

Main Methods:

  • Human studies correlating WMH burden with mLV and glymphatic drainage.
  • Longitudinal cohort analysis of glymphatic function and WMH progression.
  • Rat model of WMH to assess lymphangiogenesis, glymphatic drainage, microglial activation, and demyelination.
  • Intervention using adeno-associated virus (AAV)-mediated VEGF-C delivery to enhance mLVs.
  • VEGF-C trap strategy to inhibit mLV growth.

Main Results:

  • High WMH burden in humans is associated with delayed mLV and glymphatic drainage.
  • Glymphatic dysfunction predicts future WMH progression.
  • WMH model in rats showed impaired lymphangiogenesis, reduced glymphatic drainage, increased microglial activation, and demyelination.
  • Enhancing mLVs with AAV-VEGF-C reduced gliosis and demyelination.
  • Inhibiting mLVs exacerbated WMH pathology.

Conclusions:

  • Dysfunction of mLVs and the glymphatic pathway plays a crucial role in the progression of brain white matter injury.
  • Modulating meningeal lymphangiogenesis presents a promising therapeutic avenue for preventing and treating WMH.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
47.3K
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
30
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20